These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7292078)

  • 21. D-penicillamine induced polymyositis in juvenile chronic arthritis: report of a case.
    Swartz MO; Silver RM
    J Rheumatol; 1984 Apr; 11(2):251-2. PubMed ID: 6726729
    [No Abstract]   [Full Text] [Related]  

  • 22. Penicillamine induced myositis: correlation between urinary zinc excretion and serum creatine.
    Jimenez-Balderas FJ; Rangel J; Mintz G
    J Rheumatol; 1991 Jun; 18(6):945-7. PubMed ID: 1895284
    [No Abstract]   [Full Text] [Related]  

  • 23. D-penicillamine induced polymyositis causing complete heart block.
    Wright GD; Wilson C; Bell AL
    Clin Rheumatol; 1994 Mar; 13(1):80-2. PubMed ID: 8187449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyositis complicating D-penicillamine treatment.
    Aydintug AO; Cervera R; D'Cruz D; Ramírez G; Asherson RA; Khamashta MA; Hughes GR
    Postgrad Med J; 1991 Nov; 67(793):1018-20. PubMed ID: 1775410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody.
    Jenkins EA; Hull RG; Thomas AL
    Br J Rheumatol; 1993 Dec; 32(12):1109-10. PubMed ID: 8252325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penicillamine-induced polymyositis.
    Leden I; Libelius R
    Scand J Rheumatol; 1985; 14(1):90-3. PubMed ID: 4001884
    [No Abstract]   [Full Text] [Related]  

  • 27. Polymyositis due to D-penicillamine in a patient with systemic sclerosis.
    Santos JC; Velasco JA
    Clin Exp Dermatol; 1991 Jan; 16(1):76. PubMed ID: 2025947
    [No Abstract]   [Full Text] [Related]  

  • 28. Penicillamine-induced polymyositis.
    Machtey I; Cucher BG; Goldman AL
    Ann Intern Med; 1977 Jun; 86(6):832. PubMed ID: 869377
    [No Abstract]   [Full Text] [Related]  

  • 29. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
    Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.
    Nishikai M; Funatsu Y; Homma M
    Arch Dermatol; 1974 Aug; 110(2):253-5. PubMed ID: 4853253
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ultrastructural study of a polymyositis caused by D-penicillamine (author's transl)].
    Marty-Double C; Pagès M; Pagès AM; Pellissier J; Brousson A
    Arch Anat Cytol Pathol; 1980; 28(6):325-8. PubMed ID: 7458422
    [No Abstract]   [Full Text] [Related]  

  • 32. Penicillamine-induced myositis. Observations and unique features in two patients and review of the literature.
    Halla JT; Fallahi S; Koopman WJ
    Am J Med; 1984 Oct; 77(4):719-22. PubMed ID: 6592972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association of polymyositis and rheumatoid arthritis. Apropos of a new case not related to drug ingestion].
    Jardin H; Cailleux N; Marie I; Lévesque H; Courtois H
    Rev Med Interne; 1996; 17(4):321-4. PubMed ID: 8761796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.
    Trice JM; Pinals RS; Plitman GI
    Arch Intern Med; 1983 Jul; 143(7):1487-8. PubMed ID: 6683487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penicillamine-induced pseudo-pseudoxanthoma elasticum in a patient with rheumatoid arthritis.
    Burge S; Ryan T
    Clin Exp Dermatol; 1988 Jul; 13(4):255-8. PubMed ID: 3246093
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.
    Rosenbaum J; Katz WA; Schumacher HR
    Ann Rheum Dis; 1980 Apr; 39(2):152-4. PubMed ID: 7387219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine.
    Thomas D; Gallus AS; Brooks PM; Tampi R; Geddes R; Hill W
    Ann Rheum Dis; 1984 Jun; 43(3):402-6. PubMed ID: 6742902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine.
    Williams AJ; Fordham JN; Barnes CG; Goodwin FJ
    Ann Rheum Dis; 1986 Jan; 45(1):82-4. PubMed ID: 3954462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-penicillamine-induced myasthenia gravis in rheumatoid arthritis.
    Froelich CJ; Hashimoto F; Searles RP; Bankhurst AD
    J Rheumatol; 1979; 6(2):237-9. PubMed ID: 458795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.